Results 51 to 60 of about 20,257 (162)

HTLV-II TAX Gene [PDF]

, 2020
openaire   +1 more source

[HTLV-I AND HTLV-II in Spain].

Anales de medicina interna (Madrid, Spain : 1984), 1995
Up to October 1994, twenty-four HTLV-I and 113 HTLV-II infected persons have been identified in Spain. A third of HTLV-I carriers were immigrants coming from endemic regions. In contrast, most HTLV-II-infected persons were Spanish native drug users. Four cases of HTLV-I-associated myelopathy (TSP) were found, and three patients suffered lymphoma (ATL).
openaire   +1 more source

Prevalence of Transfusion-Transmitted Viruses Among Blood Donors at King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia (2019-2024). [PDF]

New Microbes New Infect
Sindi N, Alzahrani OA, Alamoudi LM, Sait AM, Alqahtani MA, Mufrrih SA, Alqahtani IM, Hakami NY, Sait FM, Alqahtani M, Mufrrih M.   +10 more
europepmc   +1 more source

HTLV-II among Pygmies from Cameroon

AIDS Research and Human Retroviruses, 1993
/Froment, Alain, Delaporte, E., Dazza, M.C., Larouzé, B.   +3 more
openaire   +3 more sources

Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil

Cadernos de Saúde Pública
Brazil may have the highest absolute number of HTLV-I/II seropositive individuals in the world. Screening potential blood donors for HTLV-I/II is mandatory in Brazil. The public blood center network accounts for about 80.0% of all blood collected.
Bernadette Catalan-Soares, Anna Bárbara de F. Carneiro-Proietti, Fernando Augusto Proietti   +2 more
doaj   +2 more sources

Evaluation of the immunochromatographic assay for HTLV-1/2 detection in Gabon: genotype-specific limitations in Central Africa. [PDF]

Microbiol Spectr
Oloumbou EF, Moussonda-Mouele HF, Diané A, Mbezele-Ba-Nsegue-Abessolo MC, Mfouo-Tynga I, Mouinga-Ondémé A.   +5 more
europepmc   +1 more source

The prevalence of pulmonary airway lesions is high in HTLV-1-positive rheumatoid arthritis: a cross-sectional observational study. [PDF]

Rheumatol Adv Pract
Iwao C, Umekita K, Kimura M, Murai M, Iwao K, Kudou R, Kawaguchi T, Hashiba Y, Nakai M, Hidaka T, Miyazaki T.   +10 more
europepmc   +1 more source

Therapeutic Approaches for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: Current and Emerging Strategies. [PDF]

Pathogens
Nakamura T, Satoh K.
europepmc   +1 more source

Interferon dynamics in deltaretroviruses: why HTLV-1 evades, but BLV responds. [PDF]

Mol Biol Rep
Akbarin MM, Farjami Z, Álvarez HR.
europepmc   +1 more source

Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches. [PDF]

PLoS One
Seifi N, Nezafat N, Hajizade MS, Negahdaripour M.   +3 more
europepmc   +1 more source